These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon. Xiong W, Wang X, Liu XY, Xiang L, Zheng LJ, Liu JX, Yuan ZH. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Dec; 35(12):1053-60. PubMed ID: 14673494 [Abstract] [Full Text] [Related]
3. Whole genome expression profiling of hepatitis B virus-transfected cell line reveals the potential targets of anti-HBV drugs. Ding XR, Yang J, Sun DC, Lou SK, Wang SQ. Pharmacogenomics J; 2008 Feb; 8(1):61-70. PubMed ID: 17505500 [Abstract] [Full Text] [Related]
4. [ISGF3, a critical factor of the IFN-alpha pathway in the antiviral action of HBV]. Zhang Q, Wei L, Wang Y. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Jun; 19(2):110-3. PubMed ID: 16027772 [Abstract] [Full Text] [Related]
5. The hepatitis B virus X protein up-regulates tumor necrosis factor alpha gene expression in hepatocytes. Lara-Pezzi E, Majano PL, Gómez-Gonzalo M, García-Monzón C, Moreno-Otero R, Levrero M, López-Cabrera M. Hepatology; 1998 Oct; 28(4):1013-21. PubMed ID: 9755238 [Abstract] [Full Text] [Related]
6. [Interaction of p53 with p53 response element like binding sequence at upstream of hepatitis B virus enhancer I]. Qu JH, Zhu MH, Lin J, Ni CR, Li FM, Zhu Z, Yu GZ. Ai Zheng; 2004 May; 23(5):502-7. PubMed ID: 15142443 [Abstract] [Full Text] [Related]
7. Evaluation of hepatitis B virus replication and proteomic analysis of HepG2.2.15 cell line after cyclosporine A treatment. Xie HY, Xia WL, Zhang CC, Wu LM, Ji HF, Cheng Y, Zheng SS. Acta Pharmacol Sin; 2007 Jul; 28(7):975-84. PubMed ID: 17588333 [Abstract] [Full Text] [Related]
8. Global proteome analysis of hepatitis B virus expressing human hepatoblastoma cell line HepG2. Huang Q, Wang L, Bai S, Lin W, Chen W, Lin J, Lin X. J Med Virol; 2009 Sep; 81(9):1539-50. PubMed ID: 19626621 [Abstract] [Full Text] [Related]
9. Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Kladney RD, Cui X, Bulla GA, Brunt EM, Fimmel CJ. Hepatology; 2002 Jun; 35(6):1431-40. PubMed ID: 12029628 [Abstract] [Full Text] [Related]
10. Proteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular model. Tong A, Wu L, Lin Q, Lau QC, Zhao X, Li J, Chen P, Chen L, Tang H, Huang C, Wei YQ. Proteomics; 2008 May; 8(10):2012-23. PubMed ID: 18491315 [Abstract] [Full Text] [Related]
11. [Transcriptional inhibitory effect of hepatitis B virus X protein on the expression of p53 tumor suppression gene]. Li J, Liu Y, Dai JZ, Xu DP, Zhang LX. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):26-9. PubMed ID: 16642213 [Abstract] [Full Text] [Related]
12. Antiviral effect of Curcuma longa Linn extract against hepatitis B virus replication. Kim HJ, Yoo HS, Kim JC, Park CS, Choi MS, Kim M, Choi H, Min JS, Kim YS, Yoon SW, Ahn JK. J Ethnopharmacol; 2009 Jul 15; 124(2):189-96. PubMed ID: 19409970 [Abstract] [Full Text] [Related]
13. [HBV transinfected enhances the PD-L expression of cytokines stimulating]. Wu XJ, Chen J, Zhu MH, Hong Y, Zhong L, Wang GQ. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Oct 15; 22(5):333-5. PubMed ID: 19469166 [Abstract] [Full Text] [Related]
14. Proteomic analysis of the E2F1 response in p53-negative cancer cells: new aspects in the regulation of cell survival and death. Li Z, Kreutzer M, Mikkat S, Mise N, Glocker MO, Pützer BM. Proteomics; 2006 Nov 15; 6(21):5735-45. PubMed ID: 17001603 [Abstract] [Full Text] [Related]
15. Protein profile in hepatitis B virus replicating rat primary hepatocytes and HepG2 cells by iTRAQ-coupled 2-D LC-MS/MS analysis: Insights on liver angiogenesis. Zhang J, Niu D, Sui J, Ching CB, Chen WN. Proteomics; 2009 May 15; 9(10):2836-45. PubMed ID: 19405029 [Abstract] [Full Text] [Related]
16. [Establishment of a new low-density cDNA macroarray and the application in the activity of IFN against HBV]. Guan SH, Liu HP, Yang DL, Lu MJ, Roggendorf M, Schlaak J. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep 15; 19(3):236-9. PubMed ID: 16261205 [Abstract] [Full Text] [Related]
17. Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation. Legrand A, Vadrot N, Lardeux B, Bringuier AF, Guillot R, Feldmann G. Liver Int; 2004 Apr 15; 24(2):149-60. PubMed ID: 15078480 [Abstract] [Full Text] [Related]
18. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell. Xin XM, Li GQ, Guan XR, Li D, Xu WZ, Jin YY, Gu HX. Hepatogastroenterology; 2008 Apr 15; 55(88):2178-83. PubMed ID: 19260501 [Abstract] [Full Text] [Related]
19. Activation of fibronectin gene expression by hepatitis B virus x antigen. Norton PA, Reis HM, Prince S, Larkin J, Pan J, Liu J, Gong Q, Zhu M, Feitelson MA. J Viral Hepat; 2004 Jul 15; 11(4):332-41. PubMed ID: 15230856 [Abstract] [Full Text] [Related]
20. iTRAQ-coupled 2-D LC-MS/MS analysis of protein profile associated with HBV-modulated DNA methylation. Niu D, Sui J, Zhang J, Feng H, Chen WN. Proteomics; 2009 Aug 15; 9(15):3856-68. PubMed ID: 19639599 [Abstract] [Full Text] [Related] Page: [Next] [New Search]